Close Menu

The article previously stated that a PLOS One article described the Reveal system as being able to identify a microbe's species. In fact, the article described a different Specific product. We regret the error.

NEW YORK – With a recent investment of $12.5 million, microbiology firm Specific Diagnostics aims to launch its antibiotic susceptibility platform that determines the antibiogram of a patient's blood culture in five hours, significantly less time than other systems currently on the market.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.